Asymchem Laboratories (Tianjin) 

$3.2
0
+$0+0% Wednesday 13:37

Statistik

Harga Tertinggi Hari
-
Harga Terendah Hari
-
52M Tertinggi
-
52M Terendah
-
Volum
-
Volum Purata
-
Kapasiti Pasaran
0
Nisbah P/E
0
Pendapatan Dividen
-
Dividen
-

Akan Datang

Pendapatan

25OctDijangka
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Seterusnya
0
0.94
1.89
2.83
EPS yang dijangka
1.3142766516
EPS sebenar
N/A

Orang Lain Juga Mengikuti

Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti ASLTY. Ini bukan cadangan pelaburan.

Peserta

Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.

Mengenai

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. It has a collaboration agreement with AUM Biosciences to develop and commercialize AUM 601. The company was founded in 1999 and is headquartered in Tianjin, China. AUM Biosciences.
Show more...
CEO
Dr. Hao Hong Ph.D.
Pekerja
9719
Negara
CN
ISIN
US04651E1038

Penyenaraian